CRISPR is a keen gene editing and engineering tool that won its discoverers the Nobel Prize in Chemistry. While undoubtedly upending this field, its uses do not stop there. Academy of Applied Pharmaceutical Sciences researcher Shipra Asthana gives an overview of its applications.

Adverse drug events rank along with tuberculosis and malaria as global disease burdens, thus underscoring the need for enhanced pharmacovigilance as new drugs land on the market in droves. Researcher Shipra Srivastava relates how AI is reinforcing the perimeter.